IND Approvals
Fast track LVV Development from Preclinical to Commercial Stages
LVV CDMO
Pro Lentiviral Vector
Lentiviral Vector CMC
Clinical GMP Lentiviral Vector
GMP Lentiviral Vector
PC/PV
GMP Lentiviral Vector
Preclinical
IIT/IND
Early Clinical
Late Clinical
BLA/Commercial
Technology Platform
Ready-to-use LVV packaging system with proprietary cell lines and packaging plasmids
Development Platform
Adherent and suspension systems
Manufacturing Platform
PD, Clinical GMP and GMP-grade
manufacturing, through to fill and finish
Analytical Platform
In-house comprehensive
analytical platform
GMP Batches Successfully Manufactured For Viral Vectors
IND-Enabling CMC From Cell Banking To Pilot Scale Production Release
GMP Facility For Viral Vector Manufacturing
Related Resources
FLYER
One Stop Solution for Cell Therapy IND Filing – in as little as 6 months
From LVV plasmid, to viral vector packaging, our flexible and scalable platform accelerates your time to clinic.
FLYER
GMP Viral Vector Manufacturing
Our viral vector facility has the capacity and state-of-the-art technologies to accelerate your gene or cell therapy development and manufacturing.
VIDEO
ProBio Hopewell Accelerating Transformative Medicines
Our 128,000 sq ft GMP facility is purpose-built for plasmid DNA and viral vector manufacturing, including AAV and LVV platforms.
WHITE
PAPER
PAPER
Design of Targeting Lentiviral Vectors and Their Producer Cells for in vivo CAR-T
Learn about successful LVV design, manufacturing, and downstream application for in vivo CAR-T.
Frequently Asked Questions